LEVETIRACETAM (KEPPRA): EVIDENCE-BASED POLYPHARMACY IN TWO PATIENTS WITH EPILEPSY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TOLOU GHAMARI ZAHRA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Jundishapur Journal of Chronic Disease Care Year:2016 | Volume:5 | Issue:2 Page(s): 0-0

Download Full-Text

View:

406

Download:

149

Cites:

Information Journal Paper

Title

LEVETIRACETAM (KEPPRA): EVIDENCE-BASED POLYPHARMACY IN TWO PATIENTS WITH EPILEPSY

Author(s)

TOLOU GHAMARI ZAHRA | Issue Writer Certificate

Keywords

LEVETIRACETAM

SIDE-EFFECTS

HEMATOLOGY

BIOCHEMISTRY

EPILEPSY

Abstract

Introduction: EPILEPSY is a prolonged disorder characterized by repeated violent epileptic seizures. Its managements depend on proper classification of the seizure category and the epileptic pattern. LEVETIRACETAM (Keppra®) has been approved as monotherapy or for adjunctive management of partial onset seizures, juvenile myoclonic EPILEPSY, and idiopathic generalized EPILEPSY. Case reporting of LEVETIRACETAM polypharmacy shows adverse effects linked to evidence-based clinical and laboratory data in two patients with EPILEPSY. Case reporting of LEVETIRACETAM polypharmacy, based on evidence-based clinical and laboratory data was of interest that investigated.Case Presentation: Two cases were studied, one patient was a 32-year-old male and the other was a 14-year-old female. The key words relevant to search topics were surveyed using PubMed (United States national library of medicine). Articles related to the LEVETIRACETAM prescription in epileptic patients were selected and considered separately. Pharmacotherapy based on LEVETIRACETAM, primidone, phenytoin, and topiramate in a 32-year-old epileptic male showed a decrease in white blood cell count (3400 cells/mcL), red blood cell count (4.4 mil/mm3) hemoglobin (11.8 g/dL) and hematocrit (36.7%). The drug regimen for the 14-year-old epileptic female was a LEVETIRACETAM polypharmacy in combination with primidone and sodium-valproate simultaneously. In this patient, there was a decrease in hemoglobin (10.4 g/dL) and hematocrit (34%). An increase in lymphocyte (84%) was also observed.Conclusions: Administration of AEDs in general and LEVETIRACETAM in particular should be based on attention to pharmacokinetic behavior in terms of monotherapy or polypharmacy.

Cites

No record.

References

No record.

Cite

APA: Copy

TOLOU GHAMARI, ZAHRA. (2016). LEVETIRACETAM (KEPPRA): EVIDENCE-BASED POLYPHARMACY IN TWO PATIENTS WITH EPILEPSY. JUNDISHAPUR JOURNAL OF CHRONIC DISEASE CARE, 5(2), 0-0. SID. https://sid.ir/paper/683879/en

Vancouver: Copy

TOLOU GHAMARI ZAHRA. LEVETIRACETAM (KEPPRA): EVIDENCE-BASED POLYPHARMACY IN TWO PATIENTS WITH EPILEPSY. JUNDISHAPUR JOURNAL OF CHRONIC DISEASE CARE[Internet]. 2016;5(2):0-0. Available from: https://sid.ir/paper/683879/en

IEEE: Copy

ZAHRA TOLOU GHAMARI, “LEVETIRACETAM (KEPPRA): EVIDENCE-BASED POLYPHARMACY IN TWO PATIENTS WITH EPILEPSY,” JUNDISHAPUR JOURNAL OF CHRONIC DISEASE CARE, vol. 5, no. 2, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/683879/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops